Yun Yen
2021
In 2021, Yun Yen earned a total compensation of $448.9K as Director at LIXTE BIOTECHNOLOGY HOLDINGS.
Compensation breakdown
| Option Awards | $427,047 |
|---|---|
| Other | $21,833 |
| Total | $448,880 |
Yen received $427K in option awards, accounting for 95% of the total pay in 2021.
Yen also received $21.8K in other compensation.
Rankings
In 2021, Yun Yen's compensation ranked 10,954th out of 12,415 executives tracked by ExecPay. In other words, Yen earned more than 11.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,954 out of 12,415 | 12th |
Division Manufacturing | 4,830 out of 5,505 | 12th |
Major group Chemicals And Allied Products | 2,160 out of 2,375 | 9th |
Industry group Drugs | 1,921 out of 2,096 | 8th |
Industry Pharmaceutical Preparations | 1,422 out of 1,546 | 8th |
Source: SEC filing on November 4, 2024.
Yen's colleagues
We found five more compensation records of executives who worked with Yun Yen at LIXTE BIOTECHNOLOGY HOLDINGS in 2021.